Call Today: 800-889-3898
Submit your Raptiva claim details for a free, no obligation case review
Get Started:
Raptiva lawsuits are personal injury cases in which patients injured after taking the psoriasis drug known as Raptiva seek compensation for their injuries.
First approved by the FDA in 2003, Raptiva is an immunosuppressant drug that treats the red, scaly patches of skin associated with psoriasis. Raptiva, which is generically known as efalizumab, is made and distributed by Genentech.
Despite its effectiveness, however, Raptiva is known to cause a range of serious, potentially fatal side effects, including:
Raptiva patients who develop any of the above conditions, as well as families of deceased Raptiva patients, will be entitled to compensation for their injuries and losses by pursuing a Raptiva lawsuit.
As reports of patient injuries and deaths following Raptiva use mounted, the FDA issued two nationwide Raptiva warnings:
The FDA has never issued a Raptiva recall.
However, on April 8, 2009, Genentech announced that it is voluntarily withdrawing Raptiva from U.S. markets. Over a two-month period, Genentech will slowly make Raptiva unavailable for sale in the U.S.
This prolonged withdrawal period is scheduled to allow doctors and Raptiva patients to work together to find a suitable alternative psoriasis drug.
Prospective plaintiffs can find out if they have a claim against Genentech by meeting with a Raptiva lawyer for a free initial consultation. During this meeting, Raptiva attorneys will:
Those who follow through with Raptiva lawsuits can win compensation for their:
Have you or a loved one been injured after taking Raptiva? If so, contact us to talk to an experienced Raptiva lawyer will investigate the details of your injury to determine if you are eligible to file a Raptiva lawsuit and seek out compensation for your injuries.
The U.S. Food and Drug Administration (FDA) announced a voluntary Raptiva recall, April 8, 2009. The Psoriasis drug’s manufacturer, Genentech, announced the voluntary Raptiva recall and has begun phasing the drug off the U.S. market. R...
Copyright © 2001 - 2009 Online Lawyer Source | Legal Marketing Site Designed by eJustice